z-logo
open-access-imgOpen Access
Infectious dose of Senecavirus A in market weight and neonatal pigs
Author(s) -
Alexandra Buckley,
Kelly M. Lager
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0267145
Subject(s) - infectious dose , outbreak , picornavirus , serial dilution , virology , biology , foot and mouth disease , inoculation , virus , infectious disease (medical specialty) , veterinary medicine , medicine , disease , immunology , pathology , alternative medicine , gene , rna , biochemistry
Foot-and-mouth disease virus (FMDV) is a picornavirus that produces a highly transmissible vesicular disease that can devastate meat and dairy production to such an extent that FMDV-free countries commit significant economic resources to maintain their FMDV-free status. Senecavirus A (SVA), also a picornavirus, causes vesicular disease in swine that is indistinguishable from FMDV. Since 2015, SVA outbreaks have been reported around the world requiring FMDV-free countries to investigate these cases to rule out FMDV. Understanding the pathogenesis of the SVA and its ability to transmit to naïve populations is critical to formulating control and prevention measures, which could reduce FMDV investigations. The primary objective of this study was to determine the infectious dose of SVA in market weight and neonatal pigs. A 2011 SVA isolate was serially hundred-fold diluted to create four challenge inoculums ranging from 10 6.5 to 10 0.5 TCID 50 /ml. Four market weight pigs individually housed were intranasally inoculated with 5 mL of each dose (n = 16). Serial ten-fold dilutions were used to create 6 challenge inoculums ranging from 10 5.5 to 10 0.5 TCID 50 /ml for neonatal pigs. Again, four animals in individual housing were challenged orally with 2 mL of each dose (n = 24). Detection of SVA by PCR in collected samples and/or neutralizing antibody response was utilized to classify an animal as infected. The minimum infectious dose for this study in market weight animals was 1,260 TCID 50 /ml (10 3.1 TCID 50 /ml) and for neonates it was 316 TCID 50 /ml (10 2.5 TCID 50 /ml). Knowledge of the infectious dose of SVA can guide biosecurity and disinfection measures to control the spread of SVA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here